| |||
 | |||
 |
Aloe | ||
|
Licorice | ||
| |||
| |||
| |||
|
Dehydroepiandrosterone (DHEA) | ||
| |||
|
| Pronunciation |
 (pra
MOKS een & hye droe KOR ti
sone) |
 |
| U.S. Brand Names |
| Enzone®; Pramosone®; Proctofoam®-HC; Zone-A Forte® |
|
| Generic Available |
|
No |
|
| Synonyms |
| Hydrocortisone and Pramoxine |
|
| Pharmacological Index |
|
Anesthetic/Corticosteroid |
|
| Use |
|
Treatment of severe anorectal or perianal swelling |
|
| Pregnancy Risk Factor |
|
C |
|
| Usual Dosage |
|
Apply to affected areas 3-4 times/day |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Patient Information |
|
When using rectally, the special applicator should be used, the aerosol container should not be placed in the rectum; for local application the foam can be placed on a tissue first |
|
| Nursing Implications |
|
When using rectally, the special applicator should be used, the aerosol container should not be placed in the rectum; for local application the foam can be placed on a tissue first |
|
| Dosage Forms |
|
Cream, topical: Pramoxine hydrochloride 1% and hydrocortisone acetate 0.5% (30 g); pramoxine hydrochloride 1% and hydrocortisone acetate 1% Foam, rectal: Pramoxine hydrochloride 1% and hydrocortisone acetate 1% (10 g) Lotion, topical: Pramoxine hydrochloride 1% and hydrocortisone 0.25%; pramoxine hydrochloride 1% and hydrocortisone 2.5%; pramoxine hydrochloride 2.5% and hydrocortisone 1% (37.5 mL, 120 mL, 240 mL) |
|
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
